Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chromosomes, Human, Pair 12 | 37 | 2006 | 430 | 2.140 |
Why?
|
Genes, APC | 26 | 2013 | 145 | 2.070 |
Why?
|
Noonan Syndrome | 11 | 2014 | 120 | 1.610 |
Why?
|
Chromosome Mapping | 90 | 2013 | 4615 | 1.550 |
Why?
|
Adenomatous Polyposis Coli Protein | 17 | 2013 | 181 | 1.310 |
Why?
|
Chromosomes, Human, Pair 22 | 17 | 2011 | 346 | 1.090 |
Why?
|
Recombination, Genetic | 23 | 2004 | 1519 | 1.060 |
Why?
|
Genetics, Medical | 5 | 2013 | 334 | 0.930 |
Why?
|
Intestinal Neoplasms | 10 | 2013 | 314 | 0.920 |
Why?
|
Adenomatous Polyposis Coli | 13 | 2009 | 218 | 0.870 |
Why?
|
Mutation | 68 | 2019 | 30053 | 0.850 |
Why?
|
Hybrid Cells | 65 | 2013 | 422 | 0.820 |
Why?
|
SOS1 Protein | 4 | 2010 | 40 | 0.790 |
Why?
|
DNA Repair | 22 | 2011 | 2046 | 0.750 |
Why?
|
DNA Mutational Analysis | 22 | 2015 | 4111 | 0.690 |
Why?
|
Genome, Human | 20 | 2018 | 4425 | 0.680 |
Why?
|
Disease Models, Animal | 35 | 2017 | 18255 | 0.640 |
Why?
|
Genes | 44 | 2006 | 1823 | 0.640 |
Why?
|
Base Pair Mismatch | 13 | 2011 | 92 | 0.590 |
Why?
|
Neoplasms | 25 | 2023 | 22173 | 0.580 |
Why?
|
Mutagenesis, Site-Directed | 5 | 2017 | 1693 | 0.570 |
Why?
|
DiGeorge Syndrome | 9 | 2013 | 185 | 0.570 |
Why?
|
Mice | 167 | 2017 | 81539 | 0.560 |
Why?
|
Colonic Neoplasms | 10 | 2012 | 2539 | 0.520 |
Why?
|
T-Box Domain Proteins | 5 | 2011 | 469 | 0.510 |
Why?
|
Abnormalities, Multiple | 16 | 2006 | 1423 | 0.510 |
Why?
|
DNA Mismatch Repair | 5 | 2015 | 428 | 0.510 |
Why?
|
DNA-Binding Proteins | 29 | 2013 | 9610 | 0.500 |
Why?
|
Base Sequence | 45 | 2018 | 12441 | 0.500 |
Why?
|
Chromosome Deletion | 15 | 2014 | 1386 | 0.480 |
Why?
|
Pharmacogenetics | 4 | 2011 | 675 | 0.480 |
Why?
|
Mice, Transgenic | 24 | 2013 | 9542 | 0.470 |
Why?
|
Mice, Mutant Strains | 20 | 2010 | 1749 | 0.460 |
Why?
|
Colorectal Neoplasms | 17 | 2019 | 6938 | 0.450 |
Why?
|
Animals | 196 | 2017 | 168475 | 0.440 |
Why?
|
Molecular Sequence Data | 47 | 2014 | 17635 | 0.440 |
Why?
|
Gene Expression Regulation, Neoplastic | 18 | 2018 | 8554 | 0.430 |
Why?
|
Molecular Biology | 1 | 2017 | 576 | 0.430 |
Why?
|
Cytoskeletal Proteins | 13 | 2016 | 1342 | 0.410 |
Why?
|
Genomics | 12 | 2022 | 5821 | 0.410 |
Why?
|
Genetic Markers | 23 | 2010 | 2601 | 0.410 |
Why?
|
Transfection | 17 | 2009 | 5774 | 0.410 |
Why?
|
Personal Health Services | 1 | 2011 | 24 | 0.400 |
Why?
|
MutS Homolog 2 Protein | 10 | 2013 | 197 | 0.390 |
Why?
|
Gene Rearrangement | 8 | 2018 | 1125 | 0.380 |
Why?
|
DNA | 24 | 2008 | 7213 | 0.370 |
Why?
|
Germ-Line Mutation | 6 | 2015 | 1858 | 0.370 |
Why?
|
Protein Tyrosine Phosphatases | 5 | 2007 | 457 | 0.370 |
Why?
|
Plasmids | 18 | 2008 | 2269 | 0.360 |
Why?
|
Chromosomes, Artificial, Yeast | 11 | 2000 | 113 | 0.360 |
Why?
|
Meiosis | 4 | 2008 | 328 | 0.360 |
Why?
|
Multigene Family | 11 | 2005 | 1076 | 0.350 |
Why?
|
Fungal Proteins | 4 | 2002 | 910 | 0.350 |
Why?
|
Sequence Tagged Sites | 11 | 2001 | 96 | 0.350 |
Why?
|
Gene Deletion | 12 | 2016 | 2665 | 0.340 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2012 | 718 | 0.340 |
Why?
|
Flap Endonucleases | 2 | 2007 | 17 | 0.340 |
Why?
|
Carrier Proteins | 16 | 2016 | 4937 | 0.340 |
Why?
|
Keratins | 4 | 2006 | 498 | 0.330 |
Why?
|
DNA-Directed DNA Polymerase | 4 | 2008 | 489 | 0.330 |
Why?
|
Mice, Knockout | 35 | 2010 | 14417 | 0.320 |
Why?
|
DNA Primers | 13 | 2008 | 2820 | 0.320 |
Why?
|
Cecal Neoplasms | 1 | 2008 | 26 | 0.320 |
Why?
|
Neoplasms, Experimental | 7 | 2010 | 1229 | 0.310 |
Why?
|
DNA, Recombinant | 7 | 1993 | 455 | 0.310 |
Why?
|
Adenocarcinoma | 12 | 2016 | 6345 | 0.310 |
Why?
|
Microtubule-Associated Proteins | 5 | 2015 | 1076 | 0.300 |
Why?
|
Genotype | 27 | 2014 | 12990 | 0.300 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2009 | 125 | 0.300 |
Why?
|
Clathrin | 3 | 2013 | 257 | 0.300 |
Why?
|
Genes, ras | 7 | 2009 | 654 | 0.290 |
Why?
|
Genes, p53 | 4 | 2015 | 712 | 0.290 |
Why?
|
Thymidine Kinase | 15 | 1991 | 286 | 0.290 |
Why?
|
Sequence Analysis, DNA | 15 | 2016 | 4740 | 0.290 |
Why?
|
Retinoblastoma Protein | 2 | 2008 | 672 | 0.280 |
Why?
|
Cloning, Molecular | 17 | 2002 | 4174 | 0.280 |
Why?
|
Lung Neoplasms | 7 | 2012 | 13381 | 0.280 |
Why?
|
Catechol O-Methyltransferase | 5 | 2009 | 251 | 0.280 |
Why?
|
Homozygote | 8 | 2010 | 1776 | 0.280 |
Why?
|
Embryonic and Fetal Development | 5 | 2000 | 420 | 0.270 |
Why?
|
Mass Spectrometry | 6 | 2015 | 2192 | 0.270 |
Why?
|
Saccharomyces cerevisiae Proteins | 6 | 2004 | 1841 | 0.260 |
Why?
|
Genes, Retinoblastoma | 1 | 2006 | 125 | 0.260 |
Why?
|
Medical Oncology | 2 | 2023 | 2321 | 0.260 |
Why?
|
Humans | 243 | 2023 | 761596 | 0.260 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2010 | 678 | 0.260 |
Why?
|
Exodeoxyribonucleases | 1 | 2007 | 192 | 0.260 |
Why?
|
Blood Proteins | 3 | 2011 | 1173 | 0.260 |
Why?
|
Phosphatidylinositol 3-Kinases | 5 | 2017 | 2865 | 0.250 |
Why?
|
Carcinoma, Medullary | 1 | 2006 | 115 | 0.250 |
Why?
|
Ultraviolet Rays | 4 | 2008 | 1080 | 0.250 |
Why?
|
Mice, Inbred C57BL | 39 | 2012 | 22174 | 0.250 |
Why?
|
DNA, Neoplasm | 8 | 2015 | 1745 | 0.250 |
Why?
|
Genome | 6 | 2022 | 1740 | 0.240 |
Why?
|
Heterozygote | 11 | 2011 | 2787 | 0.240 |
Why?
|
Gene Dosage | 7 | 2019 | 1218 | 0.240 |
Why?
|
Chromosomal Instability | 3 | 2016 | 178 | 0.240 |
Why?
|
beta Catenin | 9 | 2014 | 1040 | 0.240 |
Why?
|
Alleles | 12 | 2014 | 6864 | 0.240 |
Why?
|
Carcinoma, Renal Cell | 3 | 2016 | 3165 | 0.240 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 5 | 2011 | 380 | 0.230 |
Why?
|
Nuclear Proteins | 15 | 2013 | 5799 | 0.230 |
Why?
|
Nucleic Acid Hybridization | 13 | 2009 | 1302 | 0.230 |
Why?
|
Integrases | 4 | 2013 | 518 | 0.230 |
Why?
|
Sulindac | 4 | 2009 | 29 | 0.230 |
Why?
|
History, 21st Century | 3 | 2017 | 1567 | 0.230 |
Why?
|
Genetic Techniques | 6 | 1993 | 428 | 0.230 |
Why?
|
Neoplasm Proteins | 10 | 2016 | 3617 | 0.230 |
Why?
|
Trans-Activators | 9 | 2003 | 2856 | 0.230 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 5 | 2009 | 223 | 0.230 |
Why?
|
Drug Therapy | 1 | 2007 | 503 | 0.220 |
Why?
|
Thymus Gland | 2 | 2006 | 1243 | 0.220 |
Why?
|
Models, Genetic | 11 | 2019 | 3442 | 0.220 |
Why?
|
Polymerase Chain Reaction | 18 | 2009 | 6075 | 0.220 |
Why?
|
In Situ Hybridization, Fluorescence | 15 | 2007 | 2510 | 0.220 |
Why?
|
Gastrointestinal Tract | 2 | 2008 | 833 | 0.220 |
Why?
|
Multidrug Resistance-Associated Proteins | 2 | 2001 | 105 | 0.210 |
Why?
|
MAP Kinase Signaling System | 4 | 2017 | 1486 | 0.210 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 4 | 2010 | 5314 | 0.210 |
Why?
|
Gastrointestinal Neoplasms | 6 | 2006 | 954 | 0.210 |
Why?
|
DNA, Single-Stranded | 4 | 1989 | 355 | 0.210 |
Why?
|
Genes, Neoplasm | 5 | 2018 | 370 | 0.210 |
Why?
|
Sirolimus | 1 | 2010 | 1533 | 0.210 |
Why?
|
Proteome | 5 | 2013 | 1862 | 0.210 |
Why?
|
Point Mutation | 4 | 2008 | 1595 | 0.210 |
Why?
|
Genetic Linkage | 16 | 2007 | 2341 | 0.200 |
Why?
|
History, 20th Century | 3 | 2017 | 2767 | 0.200 |
Why?
|
Phenotype | 31 | 2015 | 16592 | 0.200 |
Why?
|
Oligonucleotide Array Sequence Analysis | 13 | 2012 | 3779 | 0.200 |
Why?
|
Simian virus 40 | 6 | 1984 | 291 | 0.200 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2014 | 3639 | 0.200 |
Why?
|
TOR Serine-Threonine Kinases | 4 | 2017 | 2057 | 0.190 |
Why?
|
Microfilament Proteins | 2 | 2009 | 1134 | 0.190 |
Why?
|
Polymorphism, Single Nucleotide | 8 | 2007 | 15936 | 0.190 |
Why?
|
Smad2 Protein | 5 | 2006 | 145 | 0.190 |
Why?
|
Phosphotransferases | 11 | 1991 | 303 | 0.190 |
Why?
|
Repetitive Sequences, Nucleic Acid | 7 | 2002 | 783 | 0.190 |
Why?
|
Haptoglobins | 2 | 2017 | 166 | 0.190 |
Why?
|
Endodeoxyribonucleases | 1 | 2002 | 165 | 0.190 |
Why?
|
Glucose Transporter Type 4 | 2 | 2013 | 240 | 0.190 |
Why?
|
Disease Progression | 10 | 2019 | 13510 | 0.190 |
Why?
|
ras Proteins | 4 | 2014 | 1054 | 0.180 |
Why?
|
Gene Expression Profiling | 13 | 2017 | 9420 | 0.180 |
Why?
|
Globins | 6 | 1987 | 404 | 0.180 |
Why?
|
Simplexvirus | 6 | 1991 | 803 | 0.180 |
Why?
|
Lymphatic Vessels | 3 | 2011 | 358 | 0.180 |
Why?
|
Mood Disorders | 1 | 2007 | 1127 | 0.180 |
Why?
|
Genomic Instability | 4 | 2010 | 709 | 0.180 |
Why?
|
Haplotypes | 8 | 2007 | 2713 | 0.180 |
Why?
|
Gene Targeting | 4 | 2002 | 838 | 0.170 |
Why?
|
Exons | 6 | 2016 | 2391 | 0.170 |
Why?
|
Gastrula | 1 | 1999 | 82 | 0.170 |
Why?
|
Transforming Growth Factor beta | 5 | 2013 | 1964 | 0.170 |
Why?
|
Clathrin Heavy Chains | 3 | 2013 | 27 | 0.170 |
Why?
|
Myosin Heavy Chains | 2 | 1999 | 405 | 0.170 |
Why?
|
Genomic Structural Variation | 1 | 2019 | 68 | 0.170 |
Why?
|
Trinucleotide Repeat Expansion | 3 | 2012 | 247 | 0.170 |
Why?
|
Transcription Factors | 12 | 2013 | 12130 | 0.160 |
Why?
|
Apoptosis | 14 | 2013 | 9490 | 0.160 |
Why?
|
Intracellular Signaling Peptides and Proteins | 8 | 2016 | 2872 | 0.160 |
Why?
|
Translocation, Genetic | 11 | 1997 | 1393 | 0.160 |
Why?
|
Fibroblasts | 18 | 2009 | 4142 | 0.160 |
Why?
|
Chromosomes, Human, 6-12 and X | 10 | 1980 | 69 | 0.160 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 5 | 2011 | 2273 | 0.160 |
Why?
|
Microsatellite Repeats | 7 | 2006 | 784 | 0.160 |
Why?
|
Adaptor Proteins, Signal Transducing | 11 | 2009 | 2898 | 0.150 |
Why?
|
Signal Transduction | 17 | 2017 | 23447 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2017 | 2457 | 0.150 |
Why?
|
Chromosomes, Human, 13-15 | 10 | 1977 | 49 | 0.150 |
Why?
|
Lymphoma | 5 | 2005 | 1901 | 0.150 |
Why?
|
Telomerase | 2 | 2014 | 745 | 0.150 |
Why?
|
Cell Transformation, Neoplastic | 9 | 2017 | 2827 | 0.150 |
Why?
|
Software | 3 | 2008 | 4434 | 0.150 |
Why?
|
Endometrial Neoplasms | 4 | 2014 | 1366 | 0.150 |
Why?
|
Patient Participation | 1 | 2007 | 1445 | 0.150 |
Why?
|
Gene Fusion | 2 | 2022 | 356 | 0.150 |
Why?
|
Muscle Fibers, Fast-Twitch | 1 | 1997 | 70 | 0.150 |
Why?
|
Cell Line | 33 | 2009 | 15601 | 0.150 |
Why?
|
Genetic Predisposition to Disease | 15 | 2015 | 17904 | 0.150 |
Why?
|
Antineoplastic Agents | 7 | 2013 | 13642 | 0.140 |
Why?
|
DNA Copy Number Variations | 6 | 2019 | 2020 | 0.140 |
Why?
|
Glycoproteins | 3 | 2012 | 2203 | 0.140 |
Why?
|
Pituitary Neoplasms | 1 | 2006 | 1323 | 0.140 |
Why?
|
Wnt Proteins | 2 | 2013 | 718 | 0.140 |
Why?
|
RNA, Neoplasm | 2 | 2013 | 750 | 0.140 |
Why?
|
Transformation, Genetic | 4 | 1989 | 192 | 0.140 |
Why?
|
Oncogene Fusion | 1 | 2017 | 81 | 0.140 |
Why?
|
Schizophrenia | 9 | 2009 | 6937 | 0.140 |
Why?
|
Proteomics | 3 | 2011 | 3848 | 0.140 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2013 | 952 | 0.140 |
Why?
|
Chromosomes, Human, 16-18 | 11 | 1977 | 32 | 0.140 |
Why?
|
Chromosome Aberrations | 14 | 2013 | 1768 | 0.140 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2012 | 4024 | 0.140 |
Why?
|
Computer Communication Networks | 2 | 1995 | 293 | 0.140 |
Why?
|
Female | 98 | 2017 | 392705 | 0.140 |
Why?
|
Restriction Mapping | 8 | 1998 | 851 | 0.140 |
Why?
|
Gene Amplification | 6 | 2008 | 1089 | 0.140 |
Why?
|
Nobel Prize | 1 | 2017 | 48 | 0.140 |
Why?
|
Mutation, Missense | 7 | 2012 | 2571 | 0.140 |
Why?
|
Psychotic Disorders | 5 | 2007 | 3223 | 0.140 |
Why?
|
Neurotensin | 1 | 1996 | 60 | 0.140 |
Why?
|
Adenosine Triphosphatases | 4 | 2008 | 836 | 0.140 |
Why?
|
Syndrome | 11 | 2006 | 3267 | 0.130 |
Why?
|
Rec A Recombinases | 1 | 1996 | 50 | 0.130 |
Why?
|
Carcinosarcoma | 1 | 2017 | 106 | 0.130 |
Why?
|
Genes, Bacterial | 3 | 2005 | 1073 | 0.130 |
Why?
|
Protein Kinase Inhibitors | 2 | 2010 | 5672 | 0.130 |
Why?
|
Gene Expression Regulation, Developmental | 9 | 2013 | 3612 | 0.130 |
Why?
|
Phenylalanine Hydroxylase | 1 | 1995 | 28 | 0.130 |
Why?
|
Epithelial Cells | 5 | 2013 | 3677 | 0.130 |
Why?
|
Oligodeoxyribonucleotides | 4 | 1995 | 779 | 0.130 |
Why?
|
Automation | 2 | 2008 | 586 | 0.130 |
Why?
|
Cyclin D1 | 3 | 2008 | 451 | 0.130 |
Why?
|
Polymorphism, Genetic | 6 | 2006 | 4243 | 0.130 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2005 | 1310 | 0.130 |
Why?
|
Skin | 3 | 2011 | 4484 | 0.130 |
Why?
|
Muscle, Skeletal | 5 | 2013 | 4948 | 0.130 |
Why?
|
Mice, Nude | 6 | 2017 | 3614 | 0.130 |
Why?
|
Pancreatic Elastase | 1 | 1995 | 127 | 0.130 |
Why?
|
Genetic Engineering | 4 | 1987 | 933 | 0.130 |
Why?
|
Receptors, Cell Surface | 4 | 2000 | 2822 | 0.130 |
Why?
|
Genetic Vectors | 8 | 1995 | 3396 | 0.120 |
Why?
|
Male | 89 | 2016 | 360846 | 0.120 |
Why?
|
Protein Array Analysis | 2 | 2007 | 400 | 0.120 |
Why?
|
Genes, Viral | 4 | 1984 | 649 | 0.120 |
Why?
|
Cell Survival | 5 | 2006 | 5791 | 0.120 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2010 | 1745 | 0.120 |
Why?
|
Haploinsufficiency | 1 | 2016 | 337 | 0.120 |
Why?
|
Sequence Deletion | 6 | 2008 | 1494 | 0.120 |
Why?
|
Intestinal Mucosa | 9 | 2010 | 3032 | 0.120 |
Why?
|
Conserved Sequence | 6 | 2006 | 1163 | 0.120 |
Why?
|
Interinstitutional Relations | 1 | 1995 | 236 | 0.120 |
Why?
|
Neurofibromin 1 | 2 | 2014 | 190 | 0.120 |
Why?
|
Escherichia coli Proteins | 2 | 2002 | 1067 | 0.120 |
Why?
|
Li-Fraumeni Syndrome | 1 | 2015 | 117 | 0.110 |
Why?
|
Amino Acid Sequence | 15 | 2009 | 13446 | 0.110 |
Why?
|
Adenoma | 5 | 2015 | 2163 | 0.110 |
Why?
|
Anticarcinogenic Agents | 1 | 1996 | 250 | 0.110 |
Why?
|
Germinoma | 3 | 2000 | 132 | 0.110 |
Why?
|
GRB10 Adaptor Protein | 1 | 2013 | 23 | 0.110 |
Why?
|
Embryo, Mammalian | 6 | 2006 | 1674 | 0.110 |
Why?
|
Huntington Disease | 2 | 2012 | 1144 | 0.110 |
Why?
|
Darier Disease | 3 | 1999 | 13 | 0.110 |
Why?
|
Radiation Tolerance | 2 | 2005 | 478 | 0.110 |
Why?
|
Acetyl-CoA Carboxylase | 1 | 2013 | 72 | 0.110 |
Why?
|
Muscular Diseases | 2 | 2013 | 553 | 0.110 |
Why?
|
Proteins | 10 | 2011 | 6032 | 0.110 |
Why?
|
Cecum | 3 | 2009 | 233 | 0.110 |
Why?
|
Gene Library | 5 | 2001 | 1059 | 0.110 |
Why?
|
Cosmids | 4 | 2000 | 105 | 0.110 |
Why?
|
Immunohistochemistry | 12 | 2010 | 11076 | 0.110 |
Why?
|
Pentose Phosphate Pathway | 1 | 2013 | 126 | 0.100 |
Why?
|
Muscle Contraction | 1 | 1997 | 1201 | 0.100 |
Why?
|
Skin Neoplasms | 4 | 2006 | 5821 | 0.100 |
Why?
|
Contig Mapping | 3 | 2001 | 54 | 0.100 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2014 | 332 | 0.100 |
Why?
|
Thyroid Neoplasms | 1 | 2006 | 2332 | 0.100 |
Why?
|
Repressor Proteins | 5 | 2008 | 2986 | 0.100 |
Why?
|
Oncogene Proteins, Fusion | 3 | 2017 | 1609 | 0.100 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2014 | 445 | 0.100 |
Why?
|
Genes, Mitochondrial | 1 | 2012 | 59 | 0.100 |
Why?
|
Glioblastoma | 5 | 2015 | 3483 | 0.100 |
Why?
|
Replication Protein A | 2 | 2010 | 53 | 0.100 |
Why?
|
DNA, Complementary | 6 | 1997 | 1991 | 0.100 |
Why?
|
Colon | 5 | 2008 | 1792 | 0.100 |
Why?
|
Citric Acid Cycle | 1 | 2013 | 231 | 0.100 |
Why?
|
Genes, p16 | 1 | 2012 | 160 | 0.100 |
Why?
|
Insulin-Like Growth Factor Binding Protein 2 | 1 | 2012 | 68 | 0.100 |
Why?
|
Carbohydrate Epimerases | 5 | 1976 | 46 | 0.100 |
Why?
|
Lipoproteins | 1 | 1997 | 881 | 0.100 |
Why?
|
Tumor Suppressor Proteins | 4 | 2005 | 2805 | 0.100 |
Why?
|
Sequence Homology, Amino Acid | 8 | 2009 | 2748 | 0.100 |
Why?
|
Carcinoma, Endometrioid | 1 | 2014 | 276 | 0.100 |
Why?
|
Cricetinae | 9 | 1996 | 2423 | 0.100 |
Why?
|
Carcinoembryonic Antigen | 3 | 2015 | 337 | 0.100 |
Why?
|
Proto-Oncogene Proteins | 8 | 2016 | 4514 | 0.090 |
Why?
|
DNA, Viral | 8 | 1986 | 2202 | 0.090 |
Why?
|
Face | 7 | 2006 | 1026 | 0.090 |
Why?
|
Immunoglobulin Class Switching | 2 | 2006 | 289 | 0.090 |
Why?
|
Muscles | 1 | 1996 | 1576 | 0.090 |
Why?
|
Uterine Neoplasms | 2 | 2017 | 1420 | 0.090 |
Why?
|
Neostriatum | 1 | 2012 | 247 | 0.090 |
Why?
|
Retroelements | 1 | 2012 | 163 | 0.090 |
Why?
|
Frameshift Mutation | 3 | 2002 | 392 | 0.090 |
Why?
|
Beta-Globulins | 5 | 1976 | 27 | 0.090 |
Why?
|
Plasminogen Activators | 2 | 1983 | 199 | 0.090 |
Why?
|
Demyelinating Diseases | 1 | 2013 | 352 | 0.090 |
Why?
|
Schizophrenic Psychology | 3 | 2006 | 1647 | 0.090 |
Why?
|
Pyruvate Kinase | 5 | 1976 | 189 | 0.090 |
Why?
|
Organometallic Compounds | 1 | 2014 | 647 | 0.090 |
Why?
|
Genome, Bacterial | 2 | 2006 | 783 | 0.090 |
Why?
|
Mutant Proteins | 1 | 2012 | 491 | 0.090 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2011 | 244 | 0.090 |
Why?
|
Cathepsin B | 1 | 2010 | 80 | 0.090 |
Why?
|
Mutagenesis | 4 | 2006 | 1232 | 0.090 |
Why?
|
Cyclins | 3 | 2001 | 594 | 0.090 |
Why?
|
Mixed Function Oxygenases | 1 | 2011 | 265 | 0.090 |
Why?
|
Behavior, Animal | 3 | 2011 | 1878 | 0.090 |
Why?
|
Cell Division | 8 | 2007 | 4465 | 0.090 |
Why?
|
DNA Restriction Enzymes | 6 | 1987 | 550 | 0.090 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2012 | 321 | 0.090 |
Why?
|
Testicular Neoplasms | 3 | 2002 | 799 | 0.090 |
Why?
|
Chromatin | 4 | 2016 | 2961 | 0.090 |
Why?
|
Genetic Variation | 6 | 2008 | 6567 | 0.090 |
Why?
|
rac GTP-Binding Proteins | 1 | 2010 | 162 | 0.090 |
Why?
|
Cells, Cultured | 16 | 2016 | 18966 | 0.090 |
Why?
|
Sequence Homology, Nucleic Acid | 3 | 1997 | 1058 | 0.090 |
Why?
|
Ovarian Neoplasms | 4 | 2013 | 4878 | 0.090 |
Why?
|
Lymphatic System | 1 | 2011 | 254 | 0.090 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 1 | 2010 | 56 | 0.090 |
Why?
|
Dystrophin-Associated Proteins | 5 | 2009 | 59 | 0.090 |
Why?
|
Matrix Metalloproteinases | 1 | 2012 | 393 | 0.090 |
Why?
|
Crosses, Genetic | 7 | 2010 | 750 | 0.090 |
Why?
|
Cell Line, Tumor | 7 | 2017 | 16990 | 0.080 |
Why?
|
Thioredoxin Reductase 2 | 1 | 2009 | 25 | 0.080 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2013 | 598 | 0.080 |
Why?
|
Tooth, Supernumerary | 1 | 2009 | 8 | 0.080 |
Why?
|
Armadillo Domain Proteins | 1 | 2009 | 24 | 0.080 |
Why?
|
Embryo Loss | 2 | 2006 | 55 | 0.080 |
Why?
|
Heart Defects, Congenital | 11 | 2006 | 4671 | 0.080 |
Why?
|
beta 2-Microglobulin | 5 | 1976 | 329 | 0.080 |
Why?
|
Physical Chromosome Mapping | 4 | 2002 | 183 | 0.080 |
Why?
|
Escherichia coli | 5 | 2002 | 4217 | 0.080 |
Why?
|
Saccharomyces cerevisiae | 5 | 2004 | 2688 | 0.080 |
Why?
|
Pedigree | 9 | 2015 | 4542 | 0.080 |
Why?
|
ran GTP-Binding Protein | 1 | 2009 | 53 | 0.080 |
Why?
|
Keratin-14 | 1 | 2009 | 56 | 0.080 |
Why?
|
L-Lactate Dehydrogenase | 3 | 1975 | 411 | 0.080 |
Why?
|
Visual Pathways | 1 | 2013 | 551 | 0.080 |
Why?
|
Clathrin-Coated Vesicles | 1 | 2009 | 67 | 0.080 |
Why?
|
Rad51 Recombinase | 3 | 2000 | 189 | 0.080 |
Why?
|
PTEN Phosphohydrolase | 2 | 2013 | 1115 | 0.080 |
Why?
|
Genes, Dominant | 1 | 1991 | 852 | 0.080 |
Why?
|
Human Genome Project | 3 | 2001 | 200 | 0.080 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2013 | 682 | 0.080 |
Why?
|
DNA, Bacterial | 3 | 2006 | 1479 | 0.080 |
Why?
|
Heart | 4 | 2010 | 4404 | 0.080 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2013 | 634 | 0.080 |
Why?
|
Metabolic Networks and Pathways | 1 | 2013 | 789 | 0.080 |
Why?
|
Gene Silencing | 5 | 2009 | 1509 | 0.080 |
Why?
|
Proteoglycans | 3 | 2000 | 803 | 0.080 |
Why?
|
Longevity | 2 | 2011 | 1065 | 0.080 |
Why?
|
Kidney Neoplasms | 2 | 2016 | 4251 | 0.080 |
Why?
|
Pigment Epithelium of Eye | 2 | 2000 | 209 | 0.080 |
Why?
|
RNA, Messenger | 10 | 2016 | 12794 | 0.080 |
Why?
|
Papillomaviridae | 1 | 2014 | 1119 | 0.080 |
Why?
|
Genetic Testing | 5 | 2008 | 3537 | 0.080 |
Why?
|
Algorithms | 7 | 2013 | 14033 | 0.080 |
Why?
|
Anemia, Sickle Cell | 1 | 2017 | 1063 | 0.080 |
Why?
|
Expressed Sequence Tags | 3 | 2006 | 250 | 0.080 |
Why?
|
Milk Proteins | 1 | 2009 | 163 | 0.080 |
Why?
|
Cell Adhesion Molecules | 2 | 2009 | 1601 | 0.080 |
Why?
|
Cisplatin | 3 | 2009 | 1652 | 0.080 |
Why?
|
Nucleic Acid Conformation | 2 | 1989 | 902 | 0.080 |
Why?
|
Cell Cycle Proteins | 5 | 2005 | 3449 | 0.080 |
Why?
|
X Chromosome | 2 | 1991 | 816 | 0.070 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2012 | 478 | 0.070 |
Why?
|
Quinolines | 1 | 2013 | 765 | 0.070 |
Why?
|
Genetic Association Studies | 2 | 2014 | 2735 | 0.070 |
Why?
|
Antigens, Neoplasm | 1 | 1995 | 1993 | 0.070 |
Why?
|
Gene Expression Regulation | 9 | 2006 | 11904 | 0.070 |
Why?
|
Receptors, Interleukin-3 | 1 | 2007 | 29 | 0.070 |
Why?
|
Genes, Lethal | 2 | 1999 | 223 | 0.070 |
Why?
|
Cystic Fibrosis | 1 | 2017 | 1285 | 0.070 |
Why?
|
Hyperplasia | 5 | 2006 | 1152 | 0.070 |
Why?
|
Positron-Emission Tomography | 2 | 2014 | 6484 | 0.070 |
Why?
|
Chromosomes, Human | 3 | 2014 | 441 | 0.070 |
Why?
|
Peptides | 4 | 2012 | 4358 | 0.070 |
Why?
|
DNA Methylation | 4 | 2014 | 4399 | 0.070 |
Why?
|
Mammary Glands, Animal | 1 | 2009 | 273 | 0.070 |
Why?
|
Chromosomes, Artificial, Bacterial | 3 | 2004 | 123 | 0.070 |
Why?
|
Interleukin-3 Receptor alpha Subunit | 1 | 2007 | 36 | 0.070 |
Why?
|
Imidazoles | 1 | 2013 | 1180 | 0.070 |
Why?
|
Asparagine | 1 | 2007 | 119 | 0.070 |
Why?
|
DNA Nucleotidyltransferases | 1 | 1987 | 175 | 0.070 |
Why?
|
Intestine, Small | 3 | 2009 | 1206 | 0.070 |
Why?
|
Mutagenesis, Insertional | 4 | 2012 | 656 | 0.070 |
Why?
|
DNA Repair Enzymes | 3 | 2008 | 346 | 0.070 |
Why?
|
Membrane Proteins | 4 | 2000 | 7859 | 0.070 |
Why?
|
Hemopexin | 1 | 2006 | 33 | 0.070 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2011 | 423 | 0.070 |
Why?
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2007 | 114 | 0.070 |
Why?
|
Microsatellite Instability | 4 | 2012 | 716 | 0.070 |
Why?
|
Precancerous Conditions | 5 | 2006 | 980 | 0.070 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2011 | 600 | 0.070 |
Why?
|
Sensitivity and Specificity | 7 | 2015 | 14665 | 0.070 |
Why?
|
Long-Term Potentiation | 2 | 2005 | 293 | 0.070 |
Why?
|
STAT3 Transcription Factor | 1 | 2010 | 871 | 0.070 |
Why?
|
Lipoma | 3 | 1997 | 293 | 0.070 |
Why?
|
Acute-Phase Proteins | 1 | 2007 | 250 | 0.070 |
Why?
|
Pseudomonas | 1 | 2006 | 124 | 0.070 |
Why?
|
Kanamycin Kinase | 3 | 1991 | 34 | 0.070 |
Why?
|
Mammals | 3 | 1996 | 1132 | 0.070 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2015 | 2917 | 0.070 |
Why?
|
Leukemia, Myelomonocytic, Chronic | 1 | 2007 | 92 | 0.070 |
Why?
|
Databases, Protein | 1 | 2008 | 387 | 0.070 |
Why?
|
Penetrance | 1 | 2007 | 383 | 0.060 |
Why?
|
Nerve Tissue Proteins | 3 | 2012 | 4415 | 0.060 |
Why?
|
Up-Regulation | 2 | 2013 | 4125 | 0.060 |
Why?
|
Host-Pathogen Interactions | 1 | 2014 | 1459 | 0.060 |
Why?
|
B-Lymphocytes | 4 | 2009 | 4758 | 0.060 |
Why?
|
Cleft Palate | 5 | 1997 | 589 | 0.060 |
Why?
|
Survival Analysis | 3 | 2017 | 10090 | 0.060 |
Why?
|
Genes, erbB-1 | 1 | 2006 | 162 | 0.060 |
Why?
|
Virulence | 2 | 2006 | 1303 | 0.060 |
Why?
|
Calcium, Dietary | 1 | 2008 | 529 | 0.060 |
Why?
|
Molecular Imaging | 1 | 2012 | 815 | 0.060 |
Why?
|
Gene Expression | 6 | 2003 | 7581 | 0.060 |
Why?
|
Fluorescence | 1 | 2008 | 756 | 0.060 |
Why?
|
Chromans | 1 | 2005 | 117 | 0.060 |
Why?
|
Genetic Diseases, Inborn | 4 | 2001 | 604 | 0.060 |
Why?
|
Phosphoproteins | 2 | 2009 | 2448 | 0.060 |
Why?
|
Nucleotidyltransferases | 1 | 1987 | 244 | 0.060 |
Why?
|
Glial Fibrillary Acidic Protein | 2 | 1998 | 553 | 0.060 |
Why?
|
Morphogenesis | 3 | 2013 | 741 | 0.060 |
Why?
|
Cardiomegaly | 1 | 2008 | 590 | 0.060 |
Why?
|
Genes, Recessive | 1 | 2007 | 623 | 0.060 |
Why?
|
United States | 6 | 2017 | 72340 | 0.060 |
Why?
|
Chromosomes | 4 | 2008 | 578 | 0.060 |
Why?
|
Tooth | 1 | 2006 | 210 | 0.060 |
Why?
|
Plasma | 1 | 2008 | 586 | 0.060 |
Why?
|
Databases, Factual | 3 | 2001 | 7968 | 0.060 |
Why?
|
Cluster Analysis | 2 | 2015 | 2707 | 0.060 |
Why?
|
Extracellular Fluid | 1 | 2006 | 165 | 0.060 |
Why?
|
Species Specificity | 6 | 2002 | 2414 | 0.060 |
Why?
|
Ataxia Telangiectasia | 1 | 2005 | 107 | 0.060 |
Why?
|
Ouabain | 2 | 1975 | 247 | 0.060 |
Why?
|
Survival Rate | 5 | 2016 | 12723 | 0.060 |
Why?
|
CpG Islands | 4 | 2019 | 1230 | 0.060 |
Why?
|
Regeneration | 1 | 2013 | 1512 | 0.060 |
Why?
|
Organ Specificity | 3 | 2006 | 1968 | 0.060 |
Why?
|
Blotting, Southern | 3 | 2005 | 777 | 0.060 |
Why?
|
Radiopharmaceuticals | 1 | 2014 | 2650 | 0.060 |
Why?
|
Hair Follicle | 1 | 2006 | 211 | 0.060 |
Why?
|
DNA Damage | 4 | 2008 | 2449 | 0.060 |
Why?
|
Chromosomes, Human, 1-3 | 7 | 1978 | 21 | 0.060 |
Why?
|
Hexosaminidases | 5 | 1976 | 45 | 0.060 |
Why?
|
Promoter Regions, Genetic | 2 | 2014 | 5790 | 0.060 |
Why?
|
Cell Differentiation | 8 | 2013 | 11530 | 0.060 |
Why?
|
Intelligence | 2 | 2006 | 924 | 0.060 |
Why?
|
DNA Transposable Elements | 2 | 2001 | 755 | 0.060 |
Why?
|
Microscopy, Confocal | 1 | 2010 | 1971 | 0.060 |
Why?
|
Models, Molecular | 4 | 2009 | 5439 | 0.060 |
Why?
|
Brain | 6 | 2012 | 27121 | 0.060 |
Why?
|
Cell Membrane | 3 | 2009 | 3687 | 0.060 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2010 | 874 | 0.050 |
Why?
|
Adult | 26 | 2015 | 221210 | 0.050 |
Why?
|
Cholecalciferol | 1 | 2008 | 553 | 0.050 |
Why?
|
Bipolar Disorder | 4 | 2007 | 5092 | 0.050 |
Why?
|
Cardiovascular Abnormalities | 2 | 2001 | 143 | 0.050 |
Why?
|
Intestine, Large | 1 | 2003 | 68 | 0.050 |
Why?
|
Tissue Array Analysis | 2 | 2015 | 550 | 0.050 |
Why?
|
Warfarin | 1 | 2011 | 1483 | 0.050 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2016 | 2425 | 0.050 |
Why?
|
Loss of Heterozygosity | 4 | 2010 | 662 | 0.050 |
Why?
|
Bayes Theorem | 2 | 2011 | 2330 | 0.050 |
Why?
|
Moloney murine leukemia virus | 1 | 1982 | 109 | 0.050 |
Why?
|
Thymus Neoplasms | 1 | 2005 | 274 | 0.050 |
Why?
|
Mitosis | 3 | 2004 | 1188 | 0.050 |
Why?
|
Cognition Disorders | 2 | 2007 | 3980 | 0.050 |
Why?
|
Memory, Short-Term | 1 | 2009 | 982 | 0.050 |
Why?
|
Drug Industry | 2 | 2007 | 788 | 0.050 |
Why?
|
Sulfonamides | 1 | 2012 | 1979 | 0.050 |
Why?
|
Chromatography, Liquid | 1 | 2006 | 983 | 0.050 |
Why?
|
Thiazolidinediones | 1 | 2005 | 461 | 0.050 |
Why?
|
Blotting, Northern | 2 | 1996 | 1545 | 0.050 |
Why?
|
Immunoglobulin A | 1 | 2006 | 978 | 0.050 |
Why?
|
Chromosomes, Mammalian | 1 | 2002 | 147 | 0.050 |
Why?
|
Drug Design | 1 | 2007 | 1048 | 0.050 |
Why?
|
Liposarcoma | 2 | 2002 | 289 | 0.050 |
Why?
|
Adipocytes | 1 | 2009 | 1194 | 0.050 |
Why?
|
Lectins, C-Type | 3 | 2000 | 585 | 0.050 |
Why?
|
Colitis, Ulcerative | 1 | 2014 | 1922 | 0.050 |
Why?
|
Codon, Terminator | 1 | 2002 | 124 | 0.050 |
Why?
|
Nitric Oxide | 1 | 2011 | 2136 | 0.050 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2008 | 829 | 0.050 |
Why?
|
Pyrazoles | 1 | 2012 | 2009 | 0.050 |
Why?
|
DNA Replication | 3 | 2002 | 1418 | 0.050 |
Why?
|
Fluorescent Dyes | 2 | 2008 | 1903 | 0.050 |
Why?
|
Base Composition | 3 | 2006 | 290 | 0.050 |
Why?
|
Stem Cells | 9 | 2013 | 3524 | 0.050 |
Why?
|
Lectins | 3 | 2000 | 491 | 0.050 |
Why?
|
Genetic Heterogeneity | 2 | 2002 | 732 | 0.050 |
Why?
|
Gastric Mucosa | 3 | 1999 | 604 | 0.050 |
Why?
|
Mucins | 2 | 2002 | 568 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 3810 | 0.050 |
Why?
|
Hedgehog Proteins | 1 | 2006 | 768 | 0.050 |
Why?
|
Seminoma | 1 | 2002 | 134 | 0.050 |
Why?
|
Down-Regulation | 2 | 2016 | 2919 | 0.050 |
Why?
|
Glucose | 2 | 2013 | 4347 | 0.050 |
Why?
|
Proto-Oncogenes | 1 | 2002 | 321 | 0.050 |
Why?
|
H-2 Antigens | 1 | 2001 | 357 | 0.050 |
Why?
|
Fertility | 1 | 2006 | 771 | 0.050 |
Why?
|
MicroRNAs | 2 | 2016 | 3816 | 0.050 |
Why?
|
Molecular Targeted Therapy | 1 | 2012 | 2811 | 0.050 |
Why?
|
Saccharomycetales | 1 | 2001 | 72 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2008 | 1406 | 0.050 |
Why?
|
Neurons | 3 | 2012 | 9463 | 0.050 |
Why?
|
Killer Cells, Natural | 2 | 2000 | 2201 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2013 | 11742 | 0.040 |
Why?
|
Myosin Light Chains | 1 | 2000 | 121 | 0.040 |
Why?
|
Chimera | 3 | 1997 | 453 | 0.040 |
Why?
|
Myoblasts | 2 | 2013 | 231 | 0.040 |
Why?
|
Cell Proliferation | 4 | 2016 | 10451 | 0.040 |
Why?
|
Addison Disease | 1 | 2000 | 48 | 0.040 |
Why?
|
DNA, Circular | 1 | 1980 | 97 | 0.040 |
Why?
|
Evolution, Molecular | 3 | 2006 | 1886 | 0.040 |
Why?
|
Neural Crest | 1 | 2002 | 279 | 0.040 |
Why?
|
Membrane Glycoproteins | 4 | 2000 | 3701 | 0.040 |
Why?
|
Cardiac Myosins | 1 | 2000 | 128 | 0.040 |
Why?
|
Head and Neck Neoplasms | 1 | 2014 | 2894 | 0.040 |
Why?
|
Glioma | 1 | 2015 | 3455 | 0.040 |
Why?
|
Muscle Weakness | 2 | 2006 | 412 | 0.040 |
Why?
|
DNA, Fungal | 1 | 2001 | 275 | 0.040 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2002 | 412 | 0.040 |
Why?
|
Chromosomes, Bacterial | 2 | 1999 | 281 | 0.040 |
Why?
|
Cell Transformation, Viral | 2 | 1984 | 526 | 0.040 |
Why?
|
Pigmentation Disorders | 1 | 2000 | 105 | 0.040 |
Why?
|
Receptors, Neuropeptide | 1 | 2000 | 106 | 0.040 |
Why?
|
Myxoma | 1 | 2000 | 114 | 0.040 |
Why?
|
Lacrimal Apparatus Diseases | 1 | 2000 | 72 | 0.040 |
Why?
|
Mice, Inbred BALB C | 3 | 2014 | 6214 | 0.040 |
Why?
|
Learning | 1 | 2009 | 1740 | 0.040 |
Why?
|
Transduction, Genetic | 1 | 1982 | 903 | 0.040 |
Why?
|
Epigenesis, Genetic | 1 | 2013 | 3801 | 0.040 |
Why?
|
Hemoglobins | 2 | 1976 | 1526 | 0.040 |
Why?
|
Protein Isoforms | 3 | 2009 | 1699 | 0.040 |
Why?
|
Mice, Inbred Strains | 3 | 2008 | 1762 | 0.040 |
Why?
|
Esophageal Achalasia | 1 | 2000 | 94 | 0.040 |
Why?
|
Aspirin | 1 | 2011 | 3133 | 0.040 |
Why?
|
Neoplasm Transplantation | 2 | 2016 | 2016 | 0.040 |
Why?
|
Immunoglobulin Isotypes | 1 | 1999 | 158 | 0.040 |
Why?
|
Mitochondria | 4 | 2009 | 3624 | 0.040 |
Why?
|
Smad3 Protein | 3 | 2006 | 166 | 0.040 |
Why?
|
Calcium-Transporting ATPases | 1 | 1999 | 122 | 0.040 |
Why?
|
Egg Proteins | 1 | 1999 | 57 | 0.040 |
Why?
|
Neoplasm Metastasis | 1 | 2010 | 4915 | 0.040 |
Why?
|
Registries | 1 | 2015 | 8225 | 0.040 |
Why?
|
Parathyroid Glands | 1 | 2001 | 518 | 0.040 |
Why?
|
Chromosomes, Human, Pair 6 | 2 | 2006 | 367 | 0.040 |
Why?
|
Cell Movement | 5 | 2016 | 5205 | 0.040 |
Why?
|
Homeodomain Proteins | 2 | 1998 | 2418 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 3 | 2015 | 6484 | 0.040 |
Why?
|
Esterases | 2 | 1980 | 98 | 0.040 |
Why?
|
Hepatocytes | 1 | 2006 | 1233 | 0.040 |
Why?
|
Computational Biology | 2 | 2009 | 3517 | 0.040 |
Why?
|
Vibrio cholerae | 1 | 2005 | 793 | 0.040 |
Why?
|
Chromosomes, Human, 21-22 and Y | 3 | 1975 | 45 | 0.040 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2000 | 361 | 0.040 |
Why?
|
Electroretinography | 1 | 2000 | 525 | 0.040 |
Why?
|
Ribosomal Proteins | 1 | 2000 | 371 | 0.040 |
Why?
|
Muscle Fibers, Skeletal | 2 | 2013 | 542 | 0.040 |
Why?
|
Diet | 5 | 2008 | 8075 | 0.040 |
Why?
|
Gene Frequency | 3 | 2015 | 3606 | 0.040 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2000 | 484 | 0.040 |
Why?
|
Fetal Death | 2 | 2000 | 435 | 0.040 |
Why?
|
DNA, Mitochondrial | 2 | 2014 | 865 | 0.040 |
Why?
|
Fatty Acids, Nonesterified | 1 | 1999 | 393 | 0.040 |
Why?
|
Drug Resistance | 4 | 1986 | 1596 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 858 | 0.040 |
Why?
|
Age of Onset | 3 | 2015 | 3306 | 0.040 |
Why?
|
Narcolepsy | 1 | 2000 | 199 | 0.040 |
Why?
|
Clone Cells | 16 | 1998 | 1659 | 0.040 |
Why?
|
Pregnancy | 3 | 2010 | 29890 | 0.040 |
Why?
|
DNA Fingerprinting | 1 | 1997 | 114 | 0.040 |
Why?
|
Leukemia | 2 | 1997 | 1522 | 0.040 |
Why?
|
Reference Values | 2 | 2009 | 4920 | 0.040 |
Why?
|
Microscopy, Fluorescence | 2 | 2003 | 2645 | 0.040 |
Why?
|
Genes, Essential | 1 | 1998 | 185 | 0.040 |
Why?
|
Catenins | 1 | 1997 | 44 | 0.040 |
Why?
|
Chromosome Inversion | 1 | 1997 | 120 | 0.040 |
Why?
|
Kinetics | 3 | 2011 | 6374 | 0.040 |
Why?
|
Plasmacytoma | 1 | 1978 | 171 | 0.040 |
Why?
|
Lung | 4 | 2013 | 10002 | 0.040 |
Why?
|
Neuropsychological Tests | 2 | 2007 | 7054 | 0.040 |
Why?
|
Dermatan Sulfate | 1 | 1996 | 43 | 0.040 |
Why?
|
Family | 1 | 2008 | 3195 | 0.040 |
Why?
|
Adolescent | 12 | 2015 | 88326 | 0.030 |
Why?
|
Tumor Stem Cell Assay | 1 | 2016 | 115 | 0.030 |
Why?
|
Telomere | 2 | 2001 | 943 | 0.030 |
Why?
|
Psychiatric Status Rating Scales | 4 | 2012 | 6019 | 0.030 |
Why?
|
Polycystic Kidney, Autosomal Dominant | 1 | 1998 | 166 | 0.030 |
Why?
|
Heart Neoplasms | 1 | 2000 | 362 | 0.030 |
Why?
|
Case-Control Studies | 5 | 2015 | 22176 | 0.030 |
Why?
|
Retinal Diseases | 2 | 2000 | 705 | 0.030 |
Why?
|
Models, Biological | 3 | 2013 | 9469 | 0.030 |
Why?
|
Brain Chemistry | 1 | 2000 | 960 | 0.030 |
Why?
|
Systems Integration | 2 | 1995 | 426 | 0.030 |
Why?
|
Neurofibromatosis 1 | 1 | 2002 | 561 | 0.030 |
Why?
|
Sequence Alignment | 5 | 2000 | 2180 | 0.030 |
Why?
|
Eye Proteins | 1 | 2000 | 633 | 0.030 |
Why?
|
Chondroitin Sulfate Proteoglycans | 1 | 1996 | 141 | 0.030 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2012 | 3615 | 0.030 |
Why?
|
Genes, Tumor Suppressor | 2 | 2002 | 1062 | 0.030 |
Why?
|
Clinical Trials as Topic | 2 | 2007 | 8002 | 0.030 |
Why?
|
Melanins | 1 | 1998 | 290 | 0.030 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 1997 | 247 | 0.030 |
Why?
|
Reperfusion Injury | 1 | 2003 | 1023 | 0.030 |
Why?
|
Time Factors | 8 | 2009 | 39969 | 0.030 |
Why?
|
Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2016 | 43 | 0.030 |
Why?
|
Local Area Networks | 1 | 1995 | 10 | 0.030 |
Why?
|
Child | 13 | 2014 | 80158 | 0.030 |
Why?
|
HSP40 Heat-Shock Proteins | 1 | 2016 | 83 | 0.030 |
Why?
|
Neomycin | 2 | 1986 | 92 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2016 | 3605 | 0.030 |
Why?
|
Calcium Channels | 1 | 2000 | 620 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2001 | 360 | 0.030 |
Why?
|
Cell Nucleus | 3 | 2012 | 2910 | 0.030 |
Why?
|
Child, Preschool | 9 | 2009 | 42232 | 0.030 |
Why?
|
ROC Curve | 2 | 2015 | 3578 | 0.030 |
Why?
|
Myogenic Regulatory Factors | 1 | 1996 | 103 | 0.030 |
Why?
|
Cell Fusion | 4 | 1983 | 294 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2009 | 12149 | 0.030 |
Why?
|
Protein Transport | 2 | 2013 | 1967 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2010 | 3530 | 0.030 |
Why?
|
Epithelium, Corneal | 1 | 1998 | 253 | 0.030 |
Why?
|
Tumor Cells, Cultured | 4 | 2002 | 6131 | 0.030 |
Why?
|
Maze Learning | 2 | 2011 | 483 | 0.030 |
Why?
|
Crossing Over, Genetic | 1 | 1995 | 92 | 0.030 |
Why?
|
Body Weight | 3 | 2008 | 4618 | 0.030 |
Why?
|
Gene Conversion | 2 | 1985 | 67 | 0.030 |
Why?
|
Software Design | 1 | 1995 | 171 | 0.030 |
Why?
|
Kyphosis | 1 | 1997 | 237 | 0.030 |
Why?
|
Tongue | 1 | 1998 | 403 | 0.030 |
Why?
|
Autoradiography | 1 | 1996 | 728 | 0.030 |
Why?
|
Hippocampus | 2 | 2005 | 3766 | 0.030 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 1996 | 322 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2001 | 3597 | 0.030 |
Why?
|
Connecticut | 1 | 1995 | 364 | 0.030 |
Why?
|
Triose-Phosphate Isomerase | 1 | 1975 | 45 | 0.030 |
Why?
|
Adenylate Kinase | 1 | 2015 | 102 | 0.030 |
Why?
|
Cerebral Cortex | 2 | 2009 | 5779 | 0.030 |
Why?
|
Genes, Reporter | 3 | 2008 | 1529 | 0.030 |
Why?
|
Data Display | 1 | 1995 | 175 | 0.030 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2017 | 431 | 0.030 |
Why?
|
Brain Neoplasms | 2 | 2013 | 9032 | 0.030 |
Why?
|
Central Nervous System | 2 | 2003 | 1336 | 0.030 |
Why?
|
Liver | 4 | 2006 | 7528 | 0.030 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 1996 | 386 | 0.030 |
Why?
|
Duodenum | 3 | 2003 | 490 | 0.030 |
Why?
|
Craniofacial Abnormalities | 1 | 1997 | 319 | 0.030 |
Why?
|
bcl-2-Associated X Protein | 2 | 2008 | 282 | 0.030 |
Why?
|
Synteny | 2 | 2006 | 77 | 0.030 |
Why?
|
Neuropeptides | 1 | 2000 | 944 | 0.030 |
Why?
|
Heredity | 1 | 2015 | 148 | 0.030 |
Why?
|
Chromosome Breakpoints | 1 | 2014 | 93 | 0.030 |
Why?
|
Epidermolysis Bullosa Simplex | 1 | 1994 | 12 | 0.030 |
Why?
|
Immunoglobulins | 1 | 1978 | 852 | 0.030 |
Why?
|
Cell Lineage | 3 | 2013 | 2557 | 0.030 |
Why?
|
New Zealand | 1 | 2015 | 358 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2016 | 670 | 0.030 |
Why?
|
Ophthalmoplegia | 1 | 1995 | 168 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2005 | 3113 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2012 | 5146 | 0.030 |
Why?
|
DNA Glycosylases | 1 | 2015 | 125 | 0.030 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 1 | 1996 | 141 | 0.030 |
Why?
|
Purkinje Cells | 1 | 1996 | 226 | 0.030 |
Why?
|
Corneal Diseases | 1 | 2000 | 542 | 0.030 |
Why?
|
Methods | 2 | 1990 | 1067 | 0.030 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2015 | 350 | 0.030 |
Why?
|
Cell-Free System | 2 | 1985 | 340 | 0.030 |
Why?
|
DNA, Satellite | 1 | 1994 | 66 | 0.030 |
Why?
|
Helicobacter Infections | 1 | 1997 | 388 | 0.030 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 1997 | 406 | 0.030 |
Why?
|
Renal Insufficiency | 1 | 2000 | 809 | 0.030 |
Why?
|
Cohort Studies | 6 | 2019 | 41495 | 0.030 |
Why?
|
Arm | 1 | 1997 | 589 | 0.030 |
Why?
|
Organizational Objectives | 1 | 1995 | 426 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2000 | 1410 | 0.030 |
Why?
|
Chemoprevention | 1 | 1996 | 326 | 0.030 |
Why?
|
Microtubules | 1 | 1979 | 1074 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 318 | 0.030 |
Why?
|
Pharynx | 1 | 1996 | 432 | 0.030 |
Why?
|
Factor IX | 1 | 1993 | 77 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2008 | 4016 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2001 | 5870 | 0.030 |
Why?
|
Soft Tissue Neoplasms | 1 | 2002 | 1159 | 0.030 |
Why?
|
Hematopoiesis | 2 | 2005 | 2050 | 0.030 |
Why?
|
New York City | 1 | 1995 | 731 | 0.030 |
Why?
|
Alternative Splicing | 2 | 2008 | 1093 | 0.030 |
Why?
|
Chromosomes, Human, 4-5 | 3 | 1980 | 26 | 0.030 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2015 | 638 | 0.030 |
Why?
|
Optic Nerve | 1 | 1996 | 572 | 0.030 |
Why?
|
alpha-L-Fucosidase | 3 | 1978 | 8 | 0.030 |
Why?
|
RNA | 4 | 2003 | 2725 | 0.030 |
Why?
|
Quinazolines | 2 | 2011 | 1371 | 0.030 |
Why?
|
Infant | 5 | 2014 | 36193 | 0.030 |
Why?
|
Glycine | 2 | 2008 | 663 | 0.030 |
Why?
|
Electric Stimulation | 2 | 2005 | 1736 | 0.030 |
Why?
|
DNA Polymerase II | 1 | 2013 | 104 | 0.030 |
Why?
|
Growth Disorders | 1 | 1997 | 655 | 0.030 |
Why?
|
Virus Integration | 1 | 2014 | 304 | 0.030 |
Why?
|
Esophagus | 1 | 1998 | 1033 | 0.030 |
Why?
|
Cytokines | 1 | 2007 | 7396 | 0.030 |
Why?
|
Cornea | 1 | 2000 | 1333 | 0.030 |
Why?
|
HT29 Cells | 1 | 2012 | 193 | 0.030 |
Why?
|
Diffusion Tensor Imaging | 2 | 2013 | 2400 | 0.030 |
Why?
|
Antipsychotic Agents | 1 | 2005 | 3067 | 0.030 |
Why?
|
Kidney Diseases | 1 | 2003 | 2091 | 0.020 |
Why?
|
Genetics | 1 | 1993 | 114 | 0.020 |
Why?
|
Staining and Labeling | 3 | 1976 | 1085 | 0.020 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 1998 | 823 | 0.020 |
Why?
|
Retina | 2 | 2000 | 2659 | 0.020 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2017 | 738 | 0.020 |
Why?
|
Genes, Immediate-Early | 2 | 2003 | 102 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2009 | 1246 | 0.020 |
Why?
|
Oxazolone | 1 | 2011 | 61 | 0.020 |
Why?
|
Selection, Genetic | 2 | 2002 | 868 | 0.020 |
Why?
|
Spinal Cord | 2 | 1998 | 1819 | 0.020 |
Why?
|
Carcinogens | 2 | 2005 | 452 | 0.020 |
Why?
|
Mice, Congenic | 1 | 2011 | 97 | 0.020 |
Why?
|
Reproduction | 1 | 1996 | 645 | 0.020 |
Why?
|
Computer Simulation | 3 | 2015 | 6241 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2018 | 1363 | 0.020 |
Why?
|
Leiomyoma | 1 | 1996 | 636 | 0.020 |
Why?
|
Biotechnology | 1 | 1993 | 282 | 0.020 |
Why?
|
Cognition | 2 | 2006 | 6992 | 0.020 |
Why?
|
Australia | 1 | 2015 | 1250 | 0.020 |
Why?
|
Oocytes | 1 | 1996 | 1166 | 0.020 |
Why?
|
Karyotyping | 4 | 2005 | 1171 | 0.020 |
Why?
|
Myosins | 1 | 1992 | 405 | 0.020 |
Why?
|
Vocalization, Animal | 1 | 2011 | 94 | 0.020 |
Why?
|
Gene Knock-In Techniques | 1 | 2012 | 421 | 0.020 |
Why?
|
Breeding | 1 | 2010 | 51 | 0.020 |
Why?
|
Neuroendocrine Cells | 1 | 2011 | 62 | 0.020 |
Why?
|
Fetus | 2 | 1997 | 1863 | 0.020 |
Why?
|
Cardiovascular Diseases | 2 | 2014 | 15502 | 0.020 |
Why?
|
Ultrasonics | 1 | 2011 | 208 | 0.020 |
Why?
|
Muscle Proteins | 1 | 1996 | 1154 | 0.020 |
Why?
|
Immunoblotting | 1 | 2013 | 1646 | 0.020 |
Why?
|
Comparative Genomic Hybridization | 1 | 2011 | 473 | 0.020 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2012 | 330 | 0.020 |
Why?
|
Linkage Disequilibrium | 2 | 2006 | 1998 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2017 | 1742 | 0.020 |
Why?
|
Endometrium | 2 | 2003 | 403 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 1996 | 1502 | 0.020 |
Why?
|
Neurosciences | 1 | 1995 | 367 | 0.020 |
Why?
|
Cyclooxygenase 2 | 1 | 2012 | 597 | 0.020 |
Why?
|
Molecular Sequence Annotation | 1 | 2012 | 522 | 0.020 |
Why?
|
Transcriptional Activation | 2 | 2008 | 1756 | 0.020 |
Why?
|
International Normalized Ratio | 1 | 2011 | 382 | 0.020 |
Why?
|
Nomograms | 1 | 2011 | 230 | 0.020 |
Why?
|
Drosophila Proteins | 1 | 1999 | 1699 | 0.020 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 1996 | 874 | 0.020 |
Why?
|
Intestines | 1 | 1999 | 1910 | 0.020 |
Why?
|
Maryland | 1 | 1990 | 277 | 0.020 |
Why?
|
Middle Aged | 13 | 2015 | 220921 | 0.020 |
Why?
|
Canada | 1 | 2015 | 2122 | 0.020 |
Why?
|
MSX1 Transcription Factor | 1 | 2009 | 53 | 0.020 |
Why?
|
Gene Duplication | 2 | 2001 | 314 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 1995 | 1136 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2012 | 11122 | 0.020 |
Why?
|
Benzimidazoles | 1 | 1975 | 858 | 0.020 |
Why?
|
Nucleic Acid Heteroduplexes | 1 | 1989 | 46 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 4576 | 0.020 |
Why?
|
Electron Transport Complex IV | 1 | 2009 | 190 | 0.020 |
Why?
|
Fibroblast Growth Factor 8 | 1 | 2009 | 62 | 0.020 |
Why?
|
Sarcoma | 2 | 1997 | 1801 | 0.020 |
Why?
|
Genomic Library | 1 | 2009 | 189 | 0.020 |
Why?
|
Genetic Complementation Test | 1 | 2010 | 555 | 0.020 |
Why?
|
Decorin | 2 | 2000 | 38 | 0.020 |
Why?
|
Cytochromes c | 1 | 2009 | 173 | 0.020 |
Why?
|
User-Computer Interface | 1 | 1995 | 1400 | 0.020 |
Why?
|
Indicators and Reagents | 1 | 1990 | 462 | 0.020 |
Why?
|
Isocitrate Dehydrogenase | 4 | 1977 | 938 | 0.020 |
Why?
|
Carcinogenicity Tests | 1 | 2008 | 38 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2002 | 3847 | 0.020 |
Why?
|
rho-Associated Kinases | 1 | 2010 | 281 | 0.020 |
Why?
|
Anisotropy | 1 | 2012 | 1283 | 0.020 |
Why?
|
Goosecoid Protein | 2 | 1998 | 9 | 0.020 |
Why?
|
Codon | 2 | 2004 | 601 | 0.020 |
Why?
|
Leukocytes | 1 | 1997 | 2026 | 0.020 |
Why?
|
Filtration | 1 | 2009 | 228 | 0.020 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2011 | 705 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2016 | 3597 | 0.020 |
Why?
|
Ethylnitrosourea | 1 | 2008 | 51 | 0.020 |
Why?
|
Introns | 2 | 2002 | 981 | 0.020 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 1 | 2008 | 57 | 0.020 |
Why?
|
Mitochondrial Membranes | 1 | 2009 | 176 | 0.020 |
Why?
|
Risk Factors | 6 | 2015 | 74213 | 0.020 |
Why?
|
TRPP Cation Channels | 2 | 2000 | 177 | 0.020 |
Why?
|
Aged | 11 | 2015 | 169310 | 0.020 |
Why?
|
Antibodies, Monoclonal | 2 | 2014 | 9177 | 0.020 |
Why?
|
Deoxyribonucleoproteins | 1 | 1987 | 3 | 0.020 |
Why?
|
Organoplatinum Compounds | 1 | 2009 | 407 | 0.020 |
Why?
|
Nucleic Acid Renaturation | 1 | 1987 | 12 | 0.020 |
Why?
|
Lac Operon | 1 | 2008 | 237 | 0.020 |
Why?
|
Models, Neurological | 2 | 2009 | 1769 | 0.020 |
Why?
|
Open Reading Frames | 2 | 2005 | 815 | 0.020 |
Why?
|
Brain Mapping | 3 | 2012 | 6635 | 0.020 |
Why?
|
Epistasis, Genetic | 1 | 2010 | 352 | 0.020 |
Why?
|
COS Cells | 1 | 2009 | 1130 | 0.020 |
Why?
|
Neoplasm Staging | 2 | 2014 | 11120 | 0.020 |
Why?
|
Leucovorin | 1 | 2009 | 643 | 0.020 |
Why?
|
Co-Repressor Proteins | 1 | 2008 | 190 | 0.020 |
Why?
|
Oxidative Phosphorylation | 1 | 2009 | 496 | 0.020 |
Why?
|
Transcription, Genetic | 4 | 2003 | 7593 | 0.020 |
Why?
|
Models, Animal | 2 | 2005 | 2112 | 0.020 |
Why?
|
Radiation, Ionizing | 1 | 2008 | 251 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2017 | 2057 | 0.020 |
Why?
|
Carcinoma | 3 | 1998 | 2330 | 0.020 |
Why?
|
Molecular Weight | 2 | 1980 | 2186 | 0.020 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2012 | 740 | 0.020 |
Why?
|
Hypokinesia | 1 | 2006 | 23 | 0.020 |
Why?
|
Phosphorylation | 2 | 2009 | 8321 | 0.020 |
Why?
|
Immunity, Mucosal | 1 | 2010 | 483 | 0.020 |
Why?
|
Tryptophan-tRNA Ligase | 2 | 1976 | 16 | 0.020 |
Why?
|
Microscopy | 1 | 2011 | 903 | 0.020 |
Why?
|
Carbon Tetrachloride Poisoning | 1 | 2006 | 11 | 0.020 |
Why?
|
Disaccharidases | 2 | 1976 | 19 | 0.020 |
Why?
|
Short Interspersed Nucleotide Elements | 1 | 2006 | 41 | 0.020 |
Why?
|
Membrane Potentials | 1 | 2009 | 1090 | 0.020 |
Why?
|
Adenosine Kinase | 2 | 1976 | 13 | 0.020 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2006 | 135 | 0.020 |
Why?
|
Immune System | 1 | 2011 | 796 | 0.020 |
Why?
|
Wechsler Scales | 1 | 2006 | 257 | 0.020 |
Why?
|
Cloning, Organism | 1 | 2006 | 50 | 0.020 |
Why?
|
Obesity | 1 | 2008 | 12947 | 0.020 |
Why?
|
Hydrostatic Pressure | 1 | 2006 | 98 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2011 | 2677 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 1997 | 5485 | 0.020 |
Why?
|
Kidney | 4 | 1998 | 7048 | 0.020 |
Why?
|
Hematologic Neoplasms | 1 | 1997 | 1896 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-ets | 2 | 1997 | 315 | 0.020 |
Why?
|
Pan troglodytes | 1 | 2006 | 223 | 0.020 |
Why?
|
Rats | 3 | 2013 | 23741 | 0.020 |
Why?
|
Inflammation | 3 | 2011 | 10774 | 0.020 |
Why?
|
Tubulin | 2 | 1999 | 693 | 0.020 |
Why?
|
Software Validation | 1 | 2005 | 59 | 0.020 |
Why?
|
Gentamicins | 1 | 1986 | 243 | 0.020 |
Why?
|
Antigens, Viral | 2 | 1980 | 988 | 0.020 |
Why?
|
Protein Conformation | 3 | 2002 | 3968 | 0.020 |
Why?
|
Amino Acyl-tRNA Synthetases | 2 | 1976 | 88 | 0.020 |
Why?
|
Base Pairing | 1 | 2005 | 140 | 0.020 |
Why?
|
Amphetamines | 1 | 2005 | 143 | 0.020 |
Why?
|
Young Adult | 4 | 2015 | 59260 | 0.020 |
Why?
|
Exploratory Behavior | 1 | 2006 | 279 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2005 | 293 | 0.020 |
Why?
|
Velopharyngeal Insufficiency | 1 | 2006 | 102 | 0.010 |
Why?
|
Histones | 1 | 1995 | 2580 | 0.010 |
Why?
|
Gene Regulatory Networks | 1 | 2013 | 1745 | 0.010 |
Why?
|
Tissue Distribution | 2 | 2000 | 2264 | 0.010 |
Why?
|
Fluorouracil | 1 | 2009 | 1642 | 0.010 |
Why?
|
Urinary Bladder Neoplasms | 2 | 1989 | 2223 | 0.010 |
Why?
|
Extracellular Matrix Proteins | 2 | 2000 | 829 | 0.010 |
Why?
|
Sex Chromosomes | 2 | 2002 | 101 | 0.010 |
Why?
|
Malate Dehydrogenase | 2 | 1974 | 40 | 0.010 |
Why?
|
Valine | 1 | 2006 | 408 | 0.010 |
Why?
|
Age Factors | 2 | 1999 | 18399 | 0.010 |
Why?
|
Replicon | 1 | 1984 | 34 | 0.010 |
Why?
|
Lod Score | 2 | 1995 | 600 | 0.010 |
Why?
|
Adenosine Diphosphate | 1 | 2005 | 422 | 0.010 |
Why?
|
Isoenzymes | 3 | 1999 | 1687 | 0.010 |
Why?
|
Yeasts | 1 | 2005 | 279 | 0.010 |
Why?
|
Embryonic Development | 1 | 2009 | 721 | 0.010 |
Why?
|
Cricetulus | 1 | 1986 | 814 | 0.010 |
Why?
|
Excitatory Postsynaptic Potentials | 1 | 2005 | 369 | 0.010 |
Why?
|
Histocompatibility Antigens | 2 | 1976 | 464 | 0.010 |
Why?
|
Chromosome Disorders | 2 | 1997 | 497 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2011 | 2417 | 0.010 |
Why?
|
Interpersonal Relations | 1 | 2011 | 1436 | 0.010 |
Why?
|
Neurons, Afferent | 1 | 2006 | 498 | 0.010 |
Why?
|
Random Allocation | 1 | 2008 | 2395 | 0.010 |
Why?
|
Immunoassay | 1 | 2007 | 745 | 0.010 |
Why?
|
Diethylstilbestrol | 1 | 2003 | 87 | 0.010 |
Why?
|
Lymphoid Tissue | 1 | 2005 | 445 | 0.010 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2005 | 882 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2011 | 2915 | 0.010 |
Why?
|
Tumor Burden | 1 | 2009 | 1892 | 0.010 |
Why?
|
Testis | 2 | 1998 | 794 | 0.010 |
Why?
|
Methionine | 1 | 2006 | 572 | 0.010 |
Why?
|
Oncogenes | 2 | 2002 | 1222 | 0.010 |
Why?
|
Repetitive Sequences, Amino Acid | 1 | 2003 | 92 | 0.010 |
Why?
|
Membrane Transport Proteins | 1 | 2009 | 1035 | 0.010 |
Why?
|
In Situ Hybridization | 2 | 1998 | 1900 | 0.010 |
Why?
|
Drug Resistance, Microbial | 1 | 1986 | 825 | 0.010 |
Why?
|
Cell Cycle | 2 | 2003 | 2932 | 0.010 |
Why?
|
Haplorhini | 1 | 1984 | 525 | 0.010 |
Why?
|
MyoD Protein | 1 | 2003 | 142 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2015 | 20100 | 0.010 |
Why?
|
Azoxymethane | 1 | 2002 | 35 | 0.010 |
Why?
|
Pseudogenes | 1 | 2002 | 104 | 0.010 |
Why?
|
RNA Interference | 1 | 2011 | 2832 | 0.010 |
Why?
|
MutS DNA Mismatch-Binding Protein | 1 | 2002 | 10 | 0.010 |
Why?
|
Superoxide Dismutase | 1 | 2005 | 594 | 0.010 |
Why?
|
Operon | 1 | 1983 | 372 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2009 | 3792 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2015 | 26129 | 0.010 |
Why?
|
Mesoderm | 1 | 2006 | 674 | 0.010 |
Why?
|
Keratinocytes | 2 | 1999 | 791 | 0.010 |
Why?
|
Sex Factors | 2 | 2007 | 10554 | 0.010 |
Why?
|
PPAR gamma | 1 | 2005 | 484 | 0.010 |
Why?
|
Nociceptors | 1 | 2006 | 461 | 0.010 |
Why?
|
Buffers | 1 | 2002 | 146 | 0.010 |
Why?
|
Bromodeoxyuridine | 1 | 1982 | 311 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2011 | 3430 | 0.010 |
Why?
|
Aging | 2 | 1998 | 8710 | 0.010 |
Why?
|
Mucin-2 | 1 | 2002 | 50 | 0.010 |
Why?
|
Corpus Striatum | 1 | 2008 | 1235 | 0.010 |
Why?
|
S Phase | 1 | 2003 | 421 | 0.010 |
Why?
|
Clozapine | 1 | 2005 | 504 | 0.010 |
Why?
|
Insulin | 2 | 2009 | 6597 | 0.010 |
Why?
|
Inbreeding | 1 | 2001 | 48 | 0.010 |
Why?
|
Task Performance and Analysis | 1 | 2006 | 763 | 0.010 |
Why?
|
Response Elements | 1 | 2003 | 309 | 0.010 |
Why?
|
Tandem Mass Spectrometry | 1 | 2008 | 1188 | 0.010 |
Why?
|
Embryonic Stem Cells | 1 | 2009 | 1263 | 0.010 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2001 | 120 | 0.010 |
Why?
|
Genes, erbB-2 | 1 | 2002 | 162 | 0.010 |
Why?
|
Binding Sites | 2 | 2003 | 6056 | 0.010 |
Why?
|
Periodicals as Topic | 1 | 1993 | 1463 | 0.010 |
Why?
|
Aneuploidy | 1 | 2005 | 552 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2009 | 2139 | 0.010 |
Why?
|
GC Rich Sequence | 1 | 2001 | 18 | 0.010 |
Why?
|
Duodenal Neoplasms | 1 | 2002 | 114 | 0.010 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 2002 | 257 | 0.010 |
Why?
|
Colitis | 1 | 2010 | 1233 | 0.010 |
Why?
|
Motor Neurons | 1 | 2006 | 870 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2001 | 70 | 0.010 |
Why?
|
Kidney Tubules | 1 | 2003 | 449 | 0.010 |
Why?
|
Alanine | 1 | 2004 | 609 | 0.010 |
Why?
|
Dinucleotide Repeats | 1 | 2000 | 29 | 0.010 |
Why?
|
Protein Biosynthesis | 2 | 2000 | 2112 | 0.010 |
Why?
|
Azacitidine | 1 | 1982 | 336 | 0.010 |
Why?
|
Genes, myc | 1 | 2002 | 390 | 0.010 |
Why?
|
Genes, fos | 1 | 2001 | 176 | 0.010 |
Why?
|
Breast Neoplasms | 2 | 2013 | 21019 | 0.010 |
Why?
|
Apoptotic Protease-Activating Factor 1 | 1 | 2000 | 22 | 0.010 |
Why?
|
Melanosomes | 1 | 2000 | 33 | 0.010 |
Why?
|
Galactokinase | 1 | 1980 | 17 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 2 | 2000 | 1974 | 0.010 |
Why?
|
Bacteria | 1 | 1991 | 2199 | 0.010 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily D | 1 | 2000 | 30 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12463 | 0.010 |
Why?
|
Gene Order | 1 | 2000 | 169 | 0.010 |
Why?
|
Chromosomes, Artificial | 1 | 2000 | 3 | 0.010 |
Why?
|
Tumor Virus Infections | 1 | 1983 | 438 | 0.010 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 1 | 2000 | 142 | 0.010 |
Why?
|
Blood Vessels | 1 | 2006 | 1113 | 0.010 |
Why?
|
Receptors, Natural Killer Cell | 1 | 2000 | 57 | 0.010 |
Why?
|
Protein Phosphatase 2 | 1 | 2002 | 231 | 0.010 |
Why?
|
Adenoviridae | 2 | 1975 | 1085 | 0.010 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2001 | 283 | 0.010 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 1980 | 176 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2008 | 2386 | 0.010 |
Why?
|
Bacteriophage P1 | 1 | 1999 | 10 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 1989 | 6534 | 0.010 |
Why?
|
HLA Antigens | 2 | 1976 | 1328 | 0.010 |
Why?
|
Autistic Disorder | 1 | 2009 | 1220 | 0.010 |
Why?
|
Founder Effect | 1 | 2000 | 186 | 0.010 |
Why?
|
Massachusetts | 1 | 2012 | 8833 | 0.010 |
Why?
|
Linear Models | 1 | 2009 | 5872 | 0.010 |
Why?
|
Sebaceous Glands | 1 | 1999 | 42 | 0.010 |
Why?
|
Pons | 1 | 2000 | 240 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2004 | 1739 | 0.010 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2006 | 1988 | 0.010 |
Why?
|
Synaptic Transmission | 1 | 2005 | 1173 | 0.010 |
Why?
|
Public Sector | 1 | 2001 | 267 | 0.010 |
Why?
|
Trisomy | 1 | 2000 | 260 | 0.010 |
Why?
|
Genitalia, Male | 1 | 1999 | 87 | 0.010 |
Why?
|
Hydrolysis | 1 | 2000 | 664 | 0.010 |
Why?
|
RNA, Untranslated | 1 | 2002 | 459 | 0.010 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2000 | 418 | 0.010 |
Why?
|
Adenosine Triphosphate | 1 | 2005 | 1989 | 0.010 |
Why?
|
Pilot Projects | 1 | 2012 | 8633 | 0.010 |
Why?
|
RNA Probes | 1 | 1998 | 111 | 0.010 |
Why?
|
Consensus Sequence | 1 | 1999 | 365 | 0.010 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 1994 | 1374 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 10766 | 0.010 |
Why?
|
Goblet Cells | 1 | 2002 | 298 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15266 | 0.010 |
Why?
|
Leucine | 1 | 2000 | 548 | 0.010 |
Why?
|
In Situ Nick-End Labeling | 1 | 1999 | 613 | 0.010 |
Why?
|
Glass | 1 | 1999 | 115 | 0.010 |
Why?
|
Rabbits | 1 | 2005 | 4772 | 0.010 |
Why?
|
Optic Chiasm | 1 | 1998 | 91 | 0.010 |
Why?
|
Food, Fortified | 1 | 1999 | 190 | 0.010 |
Why?
|
Diarrhea | 1 | 2005 | 1318 | 0.010 |
Why?
|
Caspase 3 | 1 | 2000 | 731 | 0.010 |
Why?
|
Urease | 1 | 1997 | 39 | 0.010 |
Why?
|
Blotting, Western | 1 | 2005 | 5035 | 0.010 |
Why?
|
Insect Proteins | 1 | 1999 | 254 | 0.010 |
Why?
|
Chromosome Banding | 1 | 1997 | 260 | 0.010 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2000 | 898 | 0.010 |
Why?
|
Neural Inhibition | 1 | 2002 | 590 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2010 | 3549 | 0.010 |
Why?
|
Private Sector | 1 | 2001 | 398 | 0.010 |
Why?
|
Leukemia, Lymphoid | 1 | 1978 | 310 | 0.010 |
Why?
|
Asthma | 1 | 1996 | 6234 | 0.010 |
Why?
|
Spermatogenesis | 1 | 1998 | 259 | 0.010 |
Why?
|
Histocytochemistry | 1 | 1998 | 698 | 0.010 |
Why?
|
Helicobacter | 1 | 1997 | 111 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 2004 | 1787 | 0.010 |
Why?
|
Epidermal Growth Factor | 1 | 1980 | 702 | 0.010 |
Why?
|
Aged, 80 and over | 4 | 2011 | 58984 | 0.010 |
Why?
|
Biglycan | 1 | 1996 | 10 | 0.010 |
Why?
|
Caspases | 1 | 2000 | 879 | 0.010 |
Why?
|
West Indies | 1 | 1996 | 32 | 0.010 |
Why?
|
Mental Disorders | 1 | 1997 | 6845 | 0.010 |
Why?
|
Models, Statistical | 1 | 2011 | 5079 | 0.010 |
Why?
|
Intermediate Filament Proteins | 1 | 1998 | 262 | 0.010 |
Why?
|
Galactose | 2 | 1975 | 297 | 0.010 |
Why?
|
Infertility, Male | 1 | 2000 | 395 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 3 | 2009 | 36426 | 0.010 |
Why?
|
Radiation | 1 | 1996 | 49 | 0.010 |
Why?
|
Dysthymic Disorder | 1 | 1996 | 75 | 0.010 |
Why?
|
Azure Stains | 1 | 1976 | 4 | 0.010 |
Why?
|
Activin Receptors | 1 | 1996 | 40 | 0.010 |
Why?
|
Memory | 1 | 2006 | 2193 | 0.010 |
Why?
|
Rectum | 1 | 2001 | 892 | 0.010 |
Why?
|
Microscopy, Immunoelectron | 1 | 1996 | 317 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2002 | 988 | 0.010 |
Why?
|
Neurotransmitter Agents | 1 | 2000 | 665 | 0.010 |
Why?
|
Phenothiazines | 1 | 1976 | 61 | 0.010 |
Why?
|
Activating Transcription Factor 1 | 1 | 1996 | 26 | 0.010 |
Why?
|
Motor Activity | 1 | 2006 | 2715 | 0.010 |
Why?
|
Glucose-6-Phosphate Isomerase | 1 | 1976 | 50 | 0.010 |
Why?
|
Myogenic Regulatory Factor 5 | 1 | 1996 | 26 | 0.010 |
Why?
|
Hypoxanthine Phosphoribosyltransferase | 1 | 1976 | 69 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2009 | 4062 | 0.010 |
Why?
|
Immunosorbent Techniques | 1 | 1976 | 175 | 0.010 |
Why?
|
Anticoagulants | 1 | 2011 | 4812 | 0.010 |
Why?
|
Heterogeneous-Nuclear Ribonucleoproteins | 1 | 1996 | 69 | 0.010 |
Why?
|
Dietary Fiber | 1 | 1999 | 759 | 0.010 |
Why?
|
Hybridization, Genetic | 1 | 1975 | 103 | 0.010 |
Why?
|
Polyps | 1 | 1997 | 200 | 0.010 |
Why?
|
Prevalence | 1 | 2012 | 15733 | 0.010 |
Why?
|
Nuclear Family | 1 | 1996 | 311 | 0.010 |
Why?
|
Lipidoses | 1 | 1975 | 10 | 0.010 |
Why?
|
Temperature | 1 | 2002 | 2226 | 0.010 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2002 | 1141 | 0.010 |
Why?
|
Atrophy | 1 | 2000 | 1633 | 0.010 |
Why?
|
High Mobility Group Proteins | 1 | 1996 | 177 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1976 | 861 | 0.010 |
Why?
|
Hypothalamus | 1 | 2000 | 999 | 0.010 |
Why?
|
Thiazoles | 1 | 2002 | 1517 | 0.010 |
Why?
|
Stimulation, Chemical | 1 | 1975 | 306 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 1979 | 2467 | 0.010 |
Why?
|
Dwarfism | 1 | 1996 | 138 | 0.010 |
Why?
|
Chick Embryo | 1 | 1996 | 982 | 0.010 |
Why?
|
Blood Glucose | 1 | 2009 | 6391 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2009 | 5305 | 0.010 |
Why?
|
Biological Evolution | 2 | 1997 | 1071 | 0.010 |
Why?
|
Lasers | 1 | 1999 | 952 | 0.010 |
Why?
|
Adenoviridae Infections | 1 | 1975 | 93 | 0.010 |
Why?
|
Quantitative Trait Loci | 1 | 2002 | 2116 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1998 | 2561 | 0.010 |
Why?
|
Enzymes | 1 | 1976 | 257 | 0.010 |
Why?
|
Liposarcoma, Myxoid | 1 | 1994 | 60 | 0.010 |
Why?
|
RNA, Viral | 1 | 1982 | 2846 | 0.010 |
Why?
|
Infertility, Female | 1 | 2000 | 760 | 0.010 |
Why?
|
Cysts | 1 | 1999 | 681 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2013 | 12690 | 0.010 |
Why?
|
Glycosylation | 1 | 1996 | 1097 | 0.010 |
Why?
|
Risk Assessment | 1 | 2015 | 23996 | 0.010 |
Why?
|
Intermediate Filaments | 1 | 1994 | 172 | 0.010 |
Why?
|
Organ Size | 1 | 1998 | 2254 | 0.010 |
Why?
|
Blastocyst | 1 | 1996 | 433 | 0.010 |
Why?
|
Spleen | 1 | 1999 | 2295 | 0.010 |
Why?
|
Leukemia, Myeloid | 1 | 1996 | 694 | 0.010 |
Why?
|
Ribonucleoproteins | 1 | 1996 | 372 | 0.010 |
Why?
|
Histocompatibility Testing | 1 | 1975 | 712 | 0.010 |
Why?
|
Protein Binding | 1 | 2005 | 9353 | 0.010 |
Why?
|
Cartilage | 1 | 1996 | 806 | 0.010 |
Why?
|
Virus Replication | 2 | 1978 | 2435 | 0.010 |
Why?
|
Antibody Formation | 1 | 1997 | 1395 | 0.010 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2000 | 1252 | 0.010 |
Why?
|
Melanoma | 2 | 1983 | 5709 | 0.010 |
Why?
|
Information Systems | 1 | 1995 | 396 | 0.010 |
Why?
|
Heterochromatin | 1 | 1975 | 293 | 0.010 |
Why?
|
Robotics | 1 | 1999 | 819 | 0.010 |
Why?
|
Forecasting | 1 | 2001 | 2928 | 0.010 |
Why?
|
Receptors, Notch | 1 | 1996 | 744 | 0.010 |
Why?
|
Collagen | 1 | 2000 | 2638 | 0.010 |
Why?
|
Corpus Callosum | 1 | 1996 | 751 | 0.010 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 1997 | 3708 | 0.010 |
Why?
|
Antibodies, Bacterial | 1 | 1997 | 1469 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 1994 | 1229 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20568 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2008 | 10194 | 0.010 |
Why?
|
Skin Diseases | 1 | 1999 | 1094 | 0.010 |
Why?
|
Antigens | 1 | 1976 | 1443 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2002 | 3085 | 0.010 |
Why?
|
Antigens, CD | 1 | 2000 | 4001 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 3 | 1977 | 1741 | 0.010 |
Why?
|
Enzyme Induction | 2 | 1984 | 452 | 0.010 |
Why?
|
Cytoplasm | 1 | 1974 | 1510 | 0.010 |
Why?
|
Fibrosis | 1 | 1995 | 2049 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 2006 | 15843 | 0.000 |
Why?
|
Anemia | 1 | 1997 | 1509 | 0.000 |
Why?
|
Cooperative Behavior | 1 | 1995 | 1505 | 0.000 |
Why?
|
Prospective Studies | 1 | 2011 | 54423 | 0.000 |
Why?
|
Lymphocytes | 1 | 1975 | 2612 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2014 | 80647 | 0.000 |
Why?
|
Myelodysplastic Syndromes | 1 | 1994 | 1394 | 0.000 |
Why?
|
Bone Marrow | 1 | 1994 | 2911 | 0.000 |
Why?
|
Lymph Nodes | 1 | 1994 | 3465 | 0.000 |
Why?
|
Poly A | 1 | 1982 | 181 | 0.000 |
Why?
|
Comorbidity | 1 | 1996 | 10508 | 0.000 |
Why?
|
Nucleic Acid Denaturation | 1 | 1980 | 110 | 0.000 |
Why?
|
Genes, Synthetic | 1 | 1980 | 88 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2007 | 64685 | 0.000 |
Why?
|
Leukemia, Experimental | 1 | 1980 | 225 | 0.000 |
Why?
|
Genes, Regulator | 1 | 1980 | 373 | 0.000 |
Why?
|
Dimethyl Sulfoxide | 1 | 1980 | 251 | 0.000 |
Why?
|
Isoelectric Focusing | 1 | 1978 | 150 | 0.000 |
Why?
|
Immune Sera | 1 | 1978 | 606 | 0.000 |
Why?
|
Purine-Nucleoside Phosphorylase | 1 | 1976 | 28 | 0.000 |
Why?
|
Chromosomes, Human, 19-20 | 1 | 1976 | 11 | 0.000 |
Why?
|
Electrophoresis | 1 | 1976 | 227 | 0.000 |
Why?
|
Nucleoside-Phosphate Kinase | 1 | 1975 | 24 | 0.000 |
Why?
|
Electrophoresis, Starch Gel | 1 | 1974 | 19 | 0.000 |
Why?
|
Immunogenetics | 1 | 1975 | 62 | 0.000 |
Why?
|
Precipitin Tests | 1 | 1976 | 813 | 0.000 |
Why?
|
Aminohydrolases | 1 | 1974 | 18 | 0.000 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 1975 | 321 | 0.000 |
Why?
|
Mannose | 1 | 1975 | 121 | 0.000 |
Why?
|
Uridine Monophosphate | 1 | 1975 | 68 | 0.000 |
Why?
|
Alcohol Oxidoreductases | 1 | 1974 | 169 | 0.000 |
Why?
|
Transaminases | 1 | 1974 | 199 | 0.000 |
Why?
|